ProAmpac European Launch of New High-Performance Mono PE Recyclable Film
ProAmpac, a leader in flexible packaging and material science, announces the launch of ProActive Recyclable R-2050, their newest patent-pending addition to the ProActive Recyclable® series of polyethylene-based structures, being introduced to serve the European market. R-2050’s unique performance characteristics make it an ideal replacement for conventional multi-material laminates without affecting the high-speed filling line efficiencies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230209005479/en/
R-2050’s unique performance characteristics make it an ideal replacement for conventional multi-material laminates without affecting the high-speed filling line efficiencies. (Photo: Business Wire)
R-2050 is the newest member of the ProActive Sustainability family and is available in standard and high-barrier versions to maintain or extend the shelf life of food products. Both platforms are widely recyclable in Europe through existing streams, and OPRL compliant in the UK for front-of-store drop-off.
“ProAmpac continues to deliver on our mission to help our customers meet their sustainable packaging goals. The ProActive Recyclable® R-2050 series is now produced and available in the United Kingdom and Europe as a sustainable alternative to conventional multi-material laminated structures without sacrificing performance,” states Adam Grose, chief commercial officer for ProAmpac.
Available in rollstock or premade pouches with optional recyclable reclose features, the R-2050 series is ideal for various applications, including dry foods, frozen foods, pet treats and fresh produce.
“R-2050 is engineered to have high clarity and drop resistance, excellent stiffness and dimpling resistance for a premium shelf appearance,” states Hesam Tabatabaei, global vice president of product development and innovation at ProAmpac. “R-2050 provides superior puncture resistance and excellent directional tear without the need for laser scoring. Engineered with superior heat resistance, R-2050 allows for optimal speeds, a wide operating window, and high efficiencies on high-speed horizontal, vertical, and flow wrap form fill sealing lines,” added Tabatabaei.
R-2050 utilizes ProAmpac’s award-winning high definition (HD) flexographic printed graphics and is available with matte or gloss registration to offer brands a package that pops off the shelf. In addition to the R-2050, ProAmpac offers a range of ProActive Recyclable film and paper-based flexible packaging solutions.
Come see samples of ProActive Recyclable R-2050 at ProAmpac’s stand (N34) during Packaging Innovations, 15-16 February in Birmingham, England. To set up a meeting or to learn more about how ProAmpac can help meet your sustainable packaging goals, contact marketing at Marketing@ProAmpac.com or visit ProAmpac.com/Sustainability.
About ProAmpac
ProAmpac is a leading global flexible packaging company with a comprehensive product offering, providing creative packaging solutions, industry-leading customer service and award-winning innovation to a diverse global marketplace. ProAmpac’s approach to sustainability – ProActive Sustainability® – provides innovative sustainable flexible packaging products to help our customers achieve their sustainability goals. We are guided in our work by five core values that are the basis for our success: Integrity, Intensity, Innovation, Involvement and Impact. Cincinnati-based ProAmpac is owned by Pritzker Private Capital along with management and co-investors. For more information, visit ProAmpac.com or contact Media@ProAmpac.com.
About Pritzker Private Capital
Pritzker Private Capital partners with middle-market companies based in North America with leading positions in the manufactured products and services sectors. The firm's differentiated, long duration capital base allows for efficient decision-making, broad flexibility with transaction structure and investment horizon, and alignment with all stakeholders. Pritzker Private Capital builds businesses for the long term and is an ideal partner for entrepreneur- and family-owned companies. Pritzker Private Capital is a signatory to the United Nations Principles for Responsible Investment (PRI). For more information, visit PPCPartners.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230209005479/en/
Contact information
Kristy Paulin
ProAmpac
(413) 875-9872
Kristy.Paulin@ProAmpac.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SK Capital Completes Acquisition of LISI Group’s Medical Division and Launches New Platform as Precera Medical3.11.2025 13:30:00 EET | Press release
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the specialty materials, ingredients, and life sciences sectors, has completed the previously announced acquisition of LISI Group’s (Euronext: FII) Medical division (the “Transaction”). The business has relocated its headquarters to Big Lake, Minnesota and has been renamed Precera Medical (“Precera Medical” or the “Company”), marking its emergence as a leading contract development and manufacturing organization (“CDMO”) partner for blue chip medical device original equipment manufacturers (“OEMs”) and innovators. As part of the Transaction, LISI Group retained a minority stake in the Company. Precera Medical is a leading CDMO focused on the production of high-precision components and assemblies serving global medical device OEMs. The Company transforms complex designs into reliable, manufacturable solutions for the most demanding applications including surgical robotics, minimally invasive surge
ACI Worldwide Acquires European Fintech Payment Components to Augment ACI Connetic3.11.2025 13:00:00 EET | Press release
ACI Worldwide (NASDAQ:ACIW), an original innovator in global payments technology, today announced that it has acquired Payment Components, a provider of AI-powered financial messaging and Open Banking solutions. ACI will integrate Payment Components technology into ACI Connetic, accelerating the roadmap of the industry's only cloud-native unified payments platform that seamlessly integrates account-to-account (A2A) payments, card processing, and AI-powered fraud prevention within a single, modular cloud-native architecture. Founded in 2014 in Greece, Payment Components develops software for A2A payments, API management, and financial messaging, streamlining transaction orchestration without complex payment processing. Its flexible messaging layer supports a broad message set, enhancing back-office connectivity and accelerating the deployment of localized payment schemes. ACI is wholly acquiring Payment Components, including its technology, intellectual property, talent, and customer re
SLB Unveils Groundbreaking New Agentic AI Technology for the Energy Industry3.11.2025 12:00:00 EET | Press release
Global energy technology company SLB (NYSE: SLB) today announced the launch of Tela™, an agentic AI assistant purpose-built to transform the upstream energy sector. Tela leverages agentic AI to not only automate processes but transform workflows and drive better business outcomes. Tela will be embedded in SLB’s portfolio of applications and platforms, and users will interact through a simple conversational interface. This approach enables agentic AI to act as a proactive collaborator — augmenting the workforce to achieve greater productivity and efficiency at scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251103326704/en/ Tela follows a common five-step agentic AI loop: observe, plan, generate, act and learn. This allows agents within Tela to proactively interact with their environment, adapt to new data, and continuously improve outcomes. Whether interpreting well logs, predicting drilling issues, or optimizing equip
Philip Morris International Publishes Updated Climate Transition Plan to Achieve Net Zero by 20403.11.2025 12:00:00 EET | Press release
Philip Morris International Inc. (PMI) (NYSE: PM) today announced the release of its second Climate Transition Plan (CTP 2025), presenting an updated and integrated strategy to achieve net-zero greenhouse gas (GHG) emissions across its value chain by 2040. The new plan reflects PMI’s continued commitment to a low-carbon future while aligning with science, regulatory frameworks, and stakeholder expectations, and builds on its 2021 Low-Carbon Transition Plan. Further, building on its 2022 Task Force on Climate-related Financial Disclosures (TCFD) report, the CTP 2025 details the results of a comprehensive climate change risks and opportunities (CCRO) assessment PMI conducted in 2024. “This Climate Transition Plan reinforces our commitment to sustainability as a fundamental business driver at PMI—one that is integrated, performance-based, and economically grounded," said Jacek Olczak, Chief Executive Officer. "By focusing on material climate risks and opportunities, implementing cost-effe
KCAS Bio Strengthens Board of Directors with Appointment of Paul Kirchgraber and Kurt Doyle3.11.2025 10:30:00 EET | Press release
KCAS Bio, a leading contract research organization (CRO) specializing in comprehensive bioanalytical and biomarker services, is delighted to announce the appointment of Dr. Paul Kirchgraber and Mr. Kurt Doyle to its Board of Directors. Their addition marks a significant milestone in KCAS Bio’s continued growth and strategic evolution in the global life sciences industry. KCAS Bio is headquartered in the Kansas City, Kansas metropolitan area with operating sites in the greater Philadelphia area; Lyon, France; and a partnership in Melbourne, Australia. The Company is backed by Vitruvian Partners, one of the world’s leading growth-focused investment firms. Dr. Paul Kirchgraber brings decades of leadership experience in clinical research and laboratory operations. He served as Executive Vice President and CEO of Covance, Labcorp’s Drug Development Division, where he led global teams in drug and medical device development in over 60 countries. Dr. Kirchgraber has experience running global p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom